Page last updated: 2024-11-01

norfloxacin and Infections, Helicobacter

norfloxacin has been researched along with Infections, Helicobacter in 2 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, VK1
Dhar, A1
Srinivasan, S1
Rattan, A1
Sharma, MP1
Gill, HH1
Desai, HG1
Mehta, PR1
Ranganathan, S1
Kalro, RH1
Murti, PK1
Prabhu, SR1

Trials

2 trials available for norfloxacin and Infections, Helicobacter

ArticleYear
Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug

1997
Mono and dual therapy for Helicobacter pylori associated gastritis.
    The Journal of the Association of Physicians of India, 1991, Volume: 39, Issue:10

    Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; G

1991